Discovery of Screening Biomarkers for Major Depressive Disorder in Remission by Proteomic Approach

Major depressive disorder (MDD) is a common disorder involving depressive mood and decreased motivation. Due to its high heterogeneity, novel biomarkers are required to diagnose MDD. In this study, a proteomic method was used to identify a new MDD biomarker. Using sequential window acquisition of al...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Hyebin, Mun, Sora, Joo, Eun-Jeong, Lee, Kyu Young, Kang, Hee-Gyoo, Lee, Jiyeong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8002827/
https://www.ncbi.nlm.nih.gov/pubmed/33802981
http://dx.doi.org/10.3390/diagnostics11030539

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8002827/
https://www.ncbi.nlm.nih.gov/pubmed/33802981
http://dx.doi.org/10.3390/diagnostics11030539

Ejemplares similares